Mohnarin Annual Report 2010 :Surveillance of Antimicrobial Resistance in Bacteria Isolated from Intensive Care Units
ZHANG Li,YANG Wen-hang,XIAO Meng,XU Ying-chun,ZHENG Bo,L(U) Yuan
2012-01-01
Abstract:OBJECTIVE To investigate the distribution and drug resistance of clinical isolates derived from ICU patients in China in 2010.METHODS The data of the isolates collected from ICU of 129 tertiary Mohnarin hospitals during 2010 were analyzed with WHONET 5.6.RESULTS A total of 27,034 isolates were collected in ICU during 2010,including 7078(26.2%) isolates of gram-positive bacteria and 19,956(73.8%) isolates of gram-negative bacteria.Staphylococcus spp.,Enterococcus spp.and Streptococcus spp.were the top three genus among gram-positive bacteria,whilst Acinetobacter baumannii,Pseudomonas aeruginosa,Klebsiella pneumonia,Escherichia coli(E.coli) and Stenotrophomonas maltophilia were the five most common isolates among gram-negative bacteria.The most common sampling sites were sputum,blood and urine,accounting for 63.2%,11.6% and 5.0% respectively.The detection rate of methicillin-resistant S.aureus was around 80.0%,but no vancomycin or linezolid-resistant Staphyloccus spp.were found.The resistance rates of E.faecalis and E.faecium,to vancomycin were 1.4% and 8.7%,and 1.0% and 5.9% to teicoplanin,respectively.73.9% of E.coli and 54.5% of K.pneumoniae isolates were ESBLs-producers.There were some carbapenems-resistant Enterobacteriaceae isolates.The resistance rates of E.coli and K.pneumonia to imipenem were 6.4% and-14.5%,respectively;the resistance rates of P.aeruginosa to imipenem and meropenem were 40.4% and 34.9%,and the resistance rates of A.baumannii,to imipenem and meropenem were 72.9% and 73.5%,respectively.But both P.aeruginosa and A.baumannii remained high susceptibility to polymyxin B. CONCLUSION Non-fermenting bacteria,Staphylococci,K.pneumonia and E.coli remain the predominant pathogens isolated from the patients in ICU.Bacterial resistance is serious.We should keep continuously close surveillance for the changes of bacterial resistance in ICU and control the use of antibiotics.